The use of immunopotentiators in malaria.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage; D001428:Bacterial Vaccines / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000276:immunology; D004731:Endotoxins / Q000276:immunology; D004926:Escherichia coli / Q000276:immunology; D005620:Freund's Adjuvant / Q000627:therapeutic use; D000882:Haplorhini; D007978:Levamisole / Q000276:immunology; D008253:Macaca mulatta; D008288:Malaria / Q000517:prevention & control*; D051379:Mice; D011070:Poly I-C / Q000276:immunology; D011425:Propionibacterium acnes / Q000276:immunology; D051381:Rats; D012503:Saponins / Q000276:immunology; D014611:Vaccination; D014612:Vaccines / Q000008:administration & dosage*
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine; D001428:Bacterial Vaccines; D004731:Endotoxins; D012503:Saponins; D014612:Vaccines; D007978:Levamisole; D003520:Cyclophosphamide; D005620:Freund's Adjuvant; D011070:Poly I-C